City Holding Co’s Amphastar Pharmaceuticals AMPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
Sell
-200
Closed -$4K 499
2020
Q3
$4K Hold
200
﹤0.01% 443
2020
Q2
$4K Hold
200
﹤0.01% 437
2020
Q1
$3K Hold
200
﹤0.01% 439
2019
Q4
$4K Hold
200
﹤0.01% 439
2019
Q3
$4K Sell
200
-200
-50% -$4.17K ﹤0.01% 440
2019
Q2
$8K Hold
400
﹤0.01% 396
2019
Q1
$8K Hold
400
﹤0.01% 387
2018
Q4
$8K Hold
400
﹤0.01% 375
2018
Q3
$8K Hold
400
﹤0.01% 397
2018
Q2
$6K Hold
400
﹤0.01% 420
2018
Q1
$8K Hold
400
﹤0.01% 407
2017
Q4
$8K Hold
400
﹤0.01% 418
2017
Q3
$7K Hold
400
﹤0.01% 418
2017
Q2
$7K Hold
400
﹤0.01% 431
2017
Q1
$6K Hold
400
﹤0.01% 438
2016
Q4
$7K Hold
400
﹤0.01% 396
2016
Q3
$8K Hold
400
﹤0.01% 383
2016
Q2
$6K Buy
+400
New +$5.64K ﹤0.01% 418

Other funds holding AMPH

City Holding Co's AMPH Position: Q4 2020 in Review

City Holding Co sold out of Amphastar Pharmaceuticals (AMPH) in Q4 2020, closing a stake of 200 shares — an estimated $4K sold.

City Holding Co first reported a position in AMPH in Q2 2016 and held it in 18 quarters. The position peaked at $8K in Q2 2019. 129 funds tracked by Wall St. Rank hold AMPH as of Q4 2020.

  • City Holding Co reported no remaining Amphastar Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • City Holding Co sold 200 Amphastar Pharmaceuticals shares in Q4 2020, an estimated $4K.
  • City Holding Co first reported a position in Amphastar Pharmaceuticals in Q2 2016 and held it in 18 quarters.
  • City Holding Co's Amphastar Pharmaceuticals position peaked at $8K in Q2 2019.
  • 129 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q4 2020.

Based on City Holding Co's 13F filing for Q4 2020, filed 12 Jan 2021.